EUVIMEDEUVIMED entdecken
Crossref

Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD Therapy

Xiaorong Wang, Shiqin Chen, Xue Xia, Yufan Du, Ya Wei, Wenqin Yang, Yiwei Zhang, Yujun Song, Ting Lei, Qianqian Huang, Huile Gao iD

Advanced Materials · 2025-02 · 37 (5)

DOI: 10.1002/adma.202411061 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 17.12.2024. Verfasst von Xiaorong Wang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-So…. Hauptthemen laut MEDLINE: Lysosomes, Alzheimer Disease, Endocytosis, Proteolysis. Die Arbeit wurde bisher 38-mal zitiert (Crossref) und nennt 51 Literaturangaben. Gefördert von: Higher Education Discipline Innovation Project, Innovative Research Group Project of the National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The excessive up‐regulation of receptor for advanced glycation end products (RAGE), a well‐known pathological marker, drives the onset and progression of Alzheimer's disease. Although lysosome‐targeting protein degradation has emerged as an effective therapeutic modality, the limited lysosome‐sorting efficacy greatly hindered the degradation efficiency of target proteins. Herein, a lysosome‐shuttle‐like nano‐chimera (endoTAC) is proposed based on polyvalent receptor binding mode for enhanced RAGE degradation as well as precise drug delivery. The endoTAC shows a high affinity to RAGE and enhances RAGE degradation due to its polyvalent‐interaction with RAGE. Additionally, endoTAC features increased accumulation in diseased brain and shows promise as a precise brain delivery system. After loading with simvastatin, the SV@endoTAC proves to successfully reverse pathological features both in vitro and in vivo. The work proposes that the combination of a lysosome‐targeting chimera and an effective drug delivery system can be promising in Alzheimer's disease therapy.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LysosomesAlzheimer DiseaseEndocytosisProteolysisNanoparticlesAnimalsHumansMiceSimvastatinReceptor for Advanced Glycation End ProductsBrainDrug CarriersDrug Delivery Systems

Stichwörter der Autor:innen

Alzheimer's diseaseBBB repairmentlysosome‐targeting protein degradationnano‐delivery systempolyvalent binding

Substanzen

SimvastatinReceptor for Advanced Glycation End ProductsDrug Carriers

Autor:innen und Institutionen

  • Key Laboratory of Drug-Targeting and Drug Delivery System of the Education Ministry and Sichuan Province, Sichuan Engineering Laboratory for Plant-Sourced Drug and Sichuan Research Center for Drug Precision Industrial T…

ORCID-Profile: Huile Gao

Förderung

  • Higher Education Discipline Innovation Project
  • Innovative Research Group Project of the National Natural Science Foundation of China

Zitieren

APA

Wang, X., Chen, S., Xia, X., Du, Y., Wei, Y., Yang, W., Zhang, Y., Song, Y., Lei, T., Huang, Q., & Gao, H. (2025). Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD Therapy. Advanced Materials, 37(5). https://doi.org/10.1002/adma.202411061

Vancouver

Wang X, Chen S, Xia X, Du Y, Wei Y, Yang W, et al. Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD Therapy. Advanced Materials. 2025;37(5). doi:10.1002/adma.202411061

BibTeX
@article{Wang2025,
  author = {Wang, Xiaorong and Chen, Shiqin and Xia, Xue and Du, Yufan and Wei, Ya and Yang, Wenqin and Zhang, Yiwei and Song, Yujun and Lei, Ting and Huang, Qianqian and Gao, Huile},
  title = {Lysosome‐Targeting Protein Degradation Through Endocytosis Pathway Triggered by Polyvalent Nano‐Chimera for AD Therapy},
  journal = {Advanced Materials},
  year = {2025},
  volume = {37},
  number = {5},
  doi = {10.1002/adma.202411061}
}
Kostenlos starten →